MSD Pharma Singapore

MSD Pharma Singapore, founded in 1997, is a vital part of Merck & Co., Inc. (MSD), a global leader committed to inventing for life for over 130 years. The company's mission is to save and improve lives by developing innovative medicines and vaccines for the world's most challenging diseases. MSD Pharma Singapore actively supports this by increasing healthcare access through comprehensive policies, programs, and partnerships, prioritizing patient and population health. Its core operations are centered on pioneering research and development to combat critical health threats, aiming to be a premier research-intensive biopharmaceutical entity.

Operating with an employee range of 1,000 - 5,000 individuals, MSD Pharma Singapore is a significant force in the biopharmaceutical sector. The company spearheads research into prevalent and emerging diseases, including cancer, infectious diseases like COVID-19, HIV, and Ebola, and animal diseases. This relentless pursuit of scientific advancement is key to its global aspirations. For insights into the people behind these innovations, you can Meet MSD Pharma Singapore's team. Their operational dedication and commitment to advancing medical science are paramount.

MSD Pharma Singapore's product offerings include biopharmaceuticals, vaccines, pharmaceuticals, and medicines, addressing critical unmet medical needs. The company plays a crucial role in the healthcare and pharmaceutical industries by developing and distributing treatments that enhance global health outcomes. Their strategic focus on innovation and patient well-being drives their efforts to prevent and treat diseases impacting human and animal lives worldwide.